Alterations in NOTCH1 and CDKN2A were prevalent in all T-ALL subtypes, occurring in 67% and 74% of T-ALL samples, respectively, relative to 0% and <30%, respectively, in B-ALL samples. This evidence concerns the gene CDKN2A and acute lymphoblastic leukemia.